Skip to main content
Clinical Trials/JPRN-UMIN000041659
JPRN-UMIN000041659
Not yet recruiting
未知

The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer. - Hypoxia and immunotherapy in lung cancer

Saitama Medical University International Medical Center0 sites20 target enrollmentSeptember 3, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
advanced non-small cell lung cancer
Sponsor
Saitama Medical University International Medical Center
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 3, 2020
End Date
March 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Pregnant women, lactating women and women with the possibility or intention of becoming pregnant 2\. Patients with complications that require intravenous administration of antibiotics and antifungal agents 3\.Patients who need to administer systemic steroids and other immunosuppressive drugs 4\. Patients with diabetes 5\. In addition, patients who are judged as inappropriate by the doctor's judgment

Outcomes

Primary Outcomes

Not specified

Similar Trials